Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Experience With the Occlutech Atrial Flow Regulator (Occlutech AFR) in a Failing Fontan Population

NCT07532369 is registered in ClinicalTrials.gov with Occlutech International AB as lead sponsor.

NCT NCT07532369
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07532369 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Experience With the Occlutech Atrial Flow Regulator (Occlutech AFR) in a Failing Fontan Population
Lead sponsor
Occlutech International AB
Phase
Observational
Overall status
Not yet recruiting
Start date
May 1, 2026
Completion date
September 30, 2026
Enrollment
25 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

congenital anomaly, failure of fontan type circulation, fenestration, univentricular heart